Immunocore Limited
R&D/Manufacturing
- Website
- http://www.immunocore.com/
- Membership category
- Corporate Pharma
92 Park Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RY, United Kingdom
Immunocore Limited at a glance
Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy.
About Immunocore Limited
Immunocore is a commercial-stage biotechnology company that discovered, developed and commercialized the world’s first approved T cell receptor (TCR) therapy.
Immunocore's mission is to radically improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases, by pioneering and delivering transformative immunomodulating medicines.
Built on their proprietary ImmTAX technology, Immunocore have a pipeline of investigational bispecific TCR therapies across a broad range of diseases, including multiple types of cancers, HIV, HBV, type 1 diabetes, and other autoimmune diseases.
